CN1089002C - Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease - Google Patents

Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease Download PDF

Info

Publication number
CN1089002C
CN1089002C CN99126606A CN99126606A CN1089002C CN 1089002 C CN1089002 C CN 1089002C CN 99126606 A CN99126606 A CN 99126606A CN 99126606 A CN99126606 A CN 99126606A CN 1089002 C CN1089002 C CN 1089002C
Authority
CN
China
Prior art keywords
chinese patent
patent medicine
parts
chinese
medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN99126606A
Other languages
Chinese (zh)
Other versions
CN1257732A (en
Inventor
余美旺
李玉效
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN99126606A priority Critical patent/CN1089002C/en
Publication of CN1257732A publication Critical patent/CN1257732A/en
Application granted granted Critical
Publication of CN1089002C publication Critical patent/CN1089002C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)

Abstract

The present invention discloses a Chinese patent medicine for treating ulceratiue stomatitis and Behcet's syndrome. The Chinese patent medicine for oral administration is prepared from ginseng, pangolin, yam, astragalus root, honeysuckle flower, mint, Chinese caterpillar fungus, cassia bark, saffron, etc. as raw materials. In general, the Chinese patent medicine has the functions of strengthening the spleen, invigorating qi, removing toxin, promoting wound healing, relieving inflammation, removing turgescence, eliminating putrescence, generating muscles, disperse the liver energy, regulating vital energy, activating blood circulation to dissipate blood stasis, and clearing dampness, and the present invention accords with the Chinese medicine pathogenesis of ulceratiue stomatitis. The Chinese patent medicine treats both manifestation and root cause of diseases and has the advantages of obvious clinical curative effect, high effective rate, no toxicity and harm to a human body.

Description

The Chinese patent medicine of treatment oral ulcer and behcets disease
The present invention relates to a kind of medicine for the treatment of oral ulcer and behcets disease, relate in particular to a kind of Chinese patent medicine for the treatment of oral ulcer and behcets disease.
Oral ulcer is the commonly encountered diseases of department of eye, its ulcer is sent out in positions such as oral mucosa, lip, tongue, gingiva, pharynx, larynxs well, has in batches the characteristics of outbreak repeatedly, and at present main Therapeutic Method is to take multivitamin, severe patient is taken the sugar skin hormone treatment, and curative effect can not be satisfactory.
Because people do not understand the importance of oral ulcer treatment, there is considerable patient in time not treat, and causing concurrent behcets disease, secondly the clinical symptoms of behcets disease is skin lesion, arthritis and arthralgia, lower limb vein thrombus etc. based on oral cavity, reproduction ulcer and ophthalmia.Behcets disease is immune a kind of repeated relapsing disease, and the medicine of integrative therapy primary disease is a lot of at present, but effect is undesirable, easily recurrence.
Purpose of the present invention aims to provide a kind of curative effect height, the treatment oral ulcer that is difficult for recurrence and the Chinese patent medicine of behcets disease.
Solution of the present invention is based on pathogenetic understanding and the Therapeutic Principle of motherland's medical science to oral ulcer and behcets disease, from motherland's medical treasure-house, filter out invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, and antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is let out damp and hot Chinese patent medicine clearly, makes oral Chinese patent medicine by traditional Chinese medical science prescription theory.
Chinese patent medicine of the present invention is made (consumption is a weight portion) by following traditional Chinese medicine raw:
Radix Ginseng 12-18 part Squama Manis 3-7 part Rhizoma Dioscoreae 8-12 part
Radix Astragali 17-23 part Flos Lonicerae 17-23 part Herba Menthae 17-23 part
Cordyceps 8-12 part Cortex Cinnamomi 17-23 part Stigma Croci 12-18 part
Above-mentioned Chinese medicine raw materials by weight proportion is made oral Chinese patent medicine.
The optimum weight proportioning of Chinese patent medicine of the present invention is:
10 parts of 5 portions of Rhizoma Dioscoreaes of 15 parts of Squama Maniss of Radix Ginseng
20 parts of 20 portions of Herba Menthaes of 20 portions of Flos Loniceraes of the Radix Astragali
15 parts of 20 parts of Stigma Crocis of 10 portions of Cortex Cinnamomis of Cordyceps
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
The inventor thinks that oral ulcer is many because of long-pending on the heart-fire, and spleen-heat is wet contains hyperactivity of fire caused by deficiency of YIN, fumigate in mouth, the corruption of intenseness of heat meat is due to the immunologic hypofunction, to the untimely treatment of oral ulcer, easy concurrent behcets disease therefore should be with invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is let out the damp and hot principles of formulating prescriptions that are clearly.
Flos Lonicerae, Herba Menthae heat-clearing and toxic substances removing are held back skin ulcer in the side, Rhizoma Dioscoreae spleen invigorating QI invigorating dampness removing, Squama Manis, Stigma Croci blood circulation promoting and blood stasis dispelling collateral dredging, the Radix Astragali, Radix Ginseng, Cordyceps using tonifying Qi reinforcing lungs, human body immunity improving function, Cortex Cinnamomi simultaneously using both cold and hot drugs, let the fire back to its origin is made a general survey of full side, coordinates mutually, the common cooperation, play invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling is let out damp and hot effect clearly.
For showing the therapeutic effect of Chinese patent medicine of the present invention to oral ulcer and behcets disease, the present invention has carried out system's clinical observation to 311 routine intractable oral cavity ulcers and 311 routine behcets diseases, and its curative effect statistical result is as follows:
Contrast before and after the treatment of table 1 oral ulcer
After treating before the symptom treatment
Symptom mild symptoms symptom no change sx effective percentage (%) is arranged
Gingival mucosa ulcer 242 242 00 100
Buccal mucosa ulcer 292 256 36 0 87.67
Mucosa of lip ulcer 248 246 20 99.19
Periglottis ulcer 86 80 60 93.02
Pharyngolaryngeal mucosa ulcer 152 140 12 0 92.11
Contrast before and after the treatment of table 2 behcets disease
After treating before the symptom treatment
Symptom mild symptoms symptom no change sx effective percentage (%) is arranged
Repeated relapsing aphtha 311 282 29 0 90.68
Eye damages 292 256 36 0 87.67
Genitals damages 248 246 20 99.19
Arthritis and arthralgia 86 80 60 93.02
Varicose veins of the lower extremity 242 242 00 100
Skin lesion 152 140 12 0 92.11
Wherein intractable oral cavity ulcer age of onset reckling is 9 years old, the maximum 70 years old, and medical history (discovery oral ulcer) half a year---20 years, male's 116 examples, women's 195 examples; Behcets disease age of onset reckling 15 years old, the maximum 72 years old, medical history (discovery behcets disease) a year---21 years, male's 120 examples, women's 191 examples.
Show that from above-mentioned clinical statistics data Chinese patent medicine of the present invention is to disease controlling, alleviate patient's symptom and the complication effect is obvious.
The present invention has following advantage:
1, to select natural Chinese medicinal herb for use be raw material in the present invention, each component meets the pharmaceutical control law regulation, and full side's compatibility has invigorating the spleen and benefiting QI, skin ulcer is held back in detoxifcation, antiinflammatory goes to swell, removing the necrotic tissue and promoting granulation, depressed liver-energy dispersing and QI regulating, blood circulation promoting and blood stasis dispelling, let out damp and hot effect clearly, meet the traditional Chinese medical science the pathogenetic understanding of oral ulcer, and nontoxic to human body.
2, the present invention need not decoct taking convenience.
3, treating both the principal and secondary aspects of a disease of the present invention, clinical efficacy is remarkable, and effective percentage reaches 90.68%.
Embodiment 1:
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
Radix Ginseng 15kg Squama Manis 5kg Rhizoma Dioscoreae 10kg
Radix Astragali 20kg Flos Lonicerae 20kg Herba Menthae 20kg
Cordyceps 10kg Cortex Cinnamomi 20kg Stigma Croci 15kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Manufacture method: it is clean earlier will above-mentioned nine flavor Chinese medicines to choose the decontamination choosing, and oven dry is ground into fine powder, sieves, and abundant mixing reinstalls in the 0.3g capsule and gets final product.With cobalt 60 radiation sterilizations,, can make in the capsule 2-3 and preserve well with favorable moth-proof or fungus growth.
Function with cure mainly: invigorating the spleen and benefiting QI, the detoxifcation hold back skin ulcer, be used for recurrent oral ulceration, mucosal ulcer such as tongue, cheek, lip, pharynx, larynx, gum.
Usage and consumption: oral, one time 5, three times on the one, one after each meal.
Specification: every dress 0.3g.
Storage: sealing, put shady and cool place.
Embodiment 2:
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
Radix Ginseng 12kg Squama Manis 3kg Rhizoma Dioscoreae 8kg
Radix Astragali 17kg Flos Lonicerae 17kg Herba Menthae 17kg
Cordyceps 8kg Cortex Cinnamomi 17kg Stigma Croci 12kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.
Embodiment 3:
Raw material of Chinese medicine and the weight proportion of making this Chinese patent medicine are:
Radix Ginseng 18kg Squama Manis 7kg Rhizoma Dioscoreae 12kg
Radix Astragali 23kg Flos Lonicerae 23kg Herba Menthae 23kg
Cordyceps 12kg Cortex Cinnamomi 23kg Stigma Croci 18kg
Above-mentioned Chinese medicine raw materials by weight proportion is made the oral Chinese patent medicine of capsule formulation.

Claims (2)

1, a kind of Chinese patent medicine for the treatment of oral ulcer and behcets disease is characterized in that: be made up of Radix Ginseng 12-18 part, Squama Manis 3-7 part, Rhizoma Dioscoreae 8-12 part, Radix Astragali 17-23 part, Flos Lonicerae 17-23 part, Herba Menthae 17-23 part, Cordyceps 8-12 part, Cortex Cinnamomi 17-23 part, Stigma Croci 12-18 part.
2, the Chinese patent medicine of treatment oral ulcer according to claim 1 and behcets disease is characterized in that: be made up of for 15 parts 15 parts of Radix Ginsengs, 5 parts of Squama Maniss, 10 parts of Rhizoma Dioscoreaes, 20 parts of the Radixs Astragali, 20 parts of Flos Loniceraes, 20 parts of Herba Menthaes, 10 parts of Cordyceps, 20 parts of Cortex Cinnamomis, Stigma Croci.
CN99126606A 1999-12-22 1999-12-22 Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease Expired - Fee Related CN1089002C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN99126606A CN1089002C (en) 1999-12-22 1999-12-22 Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN99126606A CN1089002C (en) 1999-12-22 1999-12-22 Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease

Publications (2)

Publication Number Publication Date
CN1257732A CN1257732A (en) 2000-06-28
CN1089002C true CN1089002C (en) 2002-08-14

Family

ID=5284476

Family Applications (1)

Application Number Title Priority Date Filing Date
CN99126606A Expired - Fee Related CN1089002C (en) 1999-12-22 1999-12-22 Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease

Country Status (1)

Country Link
CN (1) CN1089002C (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1306945C (en) * 2002-08-12 2007-03-28 董学巧 Chinese Medicinal prescription for treating oral ulcer and its production process
CN104147247B (en) * 2014-09-04 2015-03-25 尹光山 Medicine for treating Yang-deficiency Qi-weakness type recurrent oral ulceration
CN110448688A (en) * 2019-09-11 2019-11-15 徐州生物工程职业技术学院 A kind of lysozyme formulation, preparation method and application

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203807A (en) * 1998-07-24 1999-01-06 兰金初 Medicine for curing recurrent stomatocace and Behcet's syndrome
CN1207945A (en) * 1998-08-18 1999-02-17 李永刚 Balsam pear-natural indig medicine powder

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1203807A (en) * 1998-07-24 1999-01-06 兰金初 Medicine for curing recurrent stomatocace and Behcet's syndrome
CN1207945A (en) * 1998-08-18 1999-02-17 李永刚 Balsam pear-natural indig medicine powder

Also Published As

Publication number Publication date
CN1257732A (en) 2000-06-28

Similar Documents

Publication Publication Date Title
CN101053632A (en) Traditional Chinese medicine for treating thromboangitis obliterans
CN101066445A (en) Chinese medicine prepn for curing gastropathy radically
CN1695694A (en) Chinese traditional medicine for treating breast disease and preparing technique
CN1814208A (en) Oral Chinese medicine for treating and preventing recurrence of uecerative stomatitis
CN1089002C (en) Chinese patent medicine 'Suxiaokouchuangling capsule' for treating oral ulcer and Baiser's disease
CN1864733A (en) Chinese proprietary medicine for treating oral cavity inflammation
CN1208646A (en) Medicine for treating gastrointestinal ulcer and gastritis
CN1149468A (en) Powder for laryngopharyngitis
CN1895593A (en) Medicine for treating acne and its preparation
CN1163251C (en) Weishukang for treating gastrosis
CN1051471C (en) Drug composition for curing osteoporosis
CN1290545C (en) Medicine for curing coronary heart disease
CN1240426C (en) Prepared Chinese medicine for treating ulcerative stomatitis
CN1167455C (en) Medicine for treating acne and its preparing process
CN106552134A (en) A kind of Chinese medicinal formulae for treating periodontal disease
CN1170572C (en) Medicine for treating atrophic gastritis and chronic colitis and preparation method thereof
CN1085100A (en) A kind of specific tooth disease medicine
CN1296034C (en) Halitosis removing toothpaste
CN1261128C (en) Medicine for treating burn and scald, preparing method thereof
CN1281257C (en) Combination of Chinese herbal medicine for curing chronic tracheitis and chronic bronchitis
CN100384448C (en) Aphtha treating Chinese medicinal preparation
CN1150016C (en) Medicine for treating fever caused by lupus erythematosus and other immunological disease
CN1281255C (en) Medication for treating ulcer of lower limb of patients of skin disease and diabetic, and preparation method
CN106822258B (en) Traditional Chinese medicine composition for treating toothache and preparation thereof
CN1253195C (en) Anti-age capsule of traditional Chinese medicine and preparation method

Legal Events

Date Code Title Description
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C06 Publication
PB01 Publication
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee